Angidac Sept, 0.15% solution 150 ml

NSAIDS. The mechanism of action is associated with inhibition of COX enzyme and disruption of prostaglandin synthesis.

Indications

For topical application in ENT practice and dentistry: inflammatory diseases of the mouth and throat, as additional means in conservative therapy after tooth extraction, after surgical interventions and injuries (tonsillectomy, jaw fractures), calculous inflammation of the salivary glands.

For local application in obstetrics and gynecology: in the postpartum period for the prevention of postpartum infectious complications, specific vulvovaginitis (in the complex therapy), nonspecific vulvovaginitis and cervicovaginitis of any etiology (including those secondary to chemotherapy and radiotherapy), bacterial vaginosis, prevention of postoperative infectious complications in surgical gynecology.

Active ingredient

Composition

The solution for topical use is colorless or slightly yellowish, transparent, with a characteristic odor of mint.

Excipients:

ethanol (ethyl alcohol 95%) – 80.84 mg,

glycerin – 50 mg,

methyl parahydroxybenzoate – 1 mg,

menthol flavoring – 0.3 mg,

sodium saccharinate – 0.24 mg,

sodium bicarbonate – 0.11 mg,

polysorbate 20 – 0.05 mg,

Sodium hydroxide solution 1M or 0.5M hydrochloric acid solution – to pH 5.0-7.0,

water d/i – up to 1 ml.

Directions for use

Special Instructions

It is not recommended for mouthwash in children under 12 years of age.

To be used in combination products.

Contraindications

Side effects

Similarities